Joyce Taylor-Papadimitriou Selected Research

Nuclear Proteins (Protein, Nuclear)

5/2011	T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients.
10/2007	Functional analysis of the transcription repressor PLU-1/JARID1B.
7/2007	Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases.
6/2003	Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9.
12/2002	Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast cancer.
12/2002	Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein (PLU-1) which is specifically up-regulated in breast cancer.
10/2002	PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joyce Taylor-Papadimitriou Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 01/2002
24	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2002
5	Carcinoma (Carcinomatosis) 01/2015 - 10/2004
4	Neoplasm Metastasis (Metastasis) 11/2015 - 03/2011
2	Disease Progression 11/2015 - 03/2011
2	Infections 07/2013 - 01/2005
2	Carcinogenesis 10/2010 - 10/2004
2	Testicular Neoplasms (Testicular Cancer) 10/2003 - 10/2002
1	Melanoma (Melanoma, Malignant) 11/2015
1	Virus Diseases (Viral Diseases) 07/2013
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2012
1	Retinoblastoma (Glioblastoma, Retinal) 05/2011
1	Breast Diseases (Breast Disease) 03/2011
1	Adenocarcinoma 01/2011
1	Metaplasia 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 02/2010
1	Multiple Myeloma 12/2007

Drug/Important Bio-Agent (IBA)

16	Polysaccharides (Glycans)IBA 01/2021 - 04/2002
14	MucinsIBA 01/2021 - 03/2002
14	AntigensIBA 01/2015 - 01/2002
9	Mucin-1 (CA 15-3 Antigen)IBA 11/2016 - 04/2002
8	Proteins (Proteins, Gene)FDA Link 07/2012 - 04/2002
7	Glycoproteins (Glycoprotein)IBA 11/2016 - 03/2002
7	Nuclear Proteins (Protein, Nuclear)IBA 05/2011 - 10/2002
6	EpitopesIBA 01/2015 - 01/2002
5	GlycopeptidesIBA 03/2011 - 03/2002
4	SialyltransferasesIBA 01/2021 - 02/2006
4	AntibodiesIBA 11/2015 - 04/2002
4	Peptides (Polypeptides)IBA 07/2014 - 03/2002
4	EnzymesIBA 12/2012 - 03/2007
3	Histone DemethylasesIBA 01/2022 - 03/2007
3	LectinsIBA 11/2016 - 12/2012
3	CarbohydratesIBA 01/2015 - 03/2002
3	VaccinesIBA 07/2014 - 11/2004
2	Chimeric Antigen ReceptorsIBA 11/2016 - 04/2008
2	Immunoglobulin G (IgG)IBA 11/2015 - 02/2010
2	C-Type Lectins (C-Type Lectin)IBA 01/2015 - 09/2007
2	Messenger RNA (mRNA)IBA 12/2012 - 10/2003
2	Monoclonal AntibodiesIBA 07/2012 - 03/2002
2	Sialyl Lewis X AntigenIBA 07/2012 - 12/2011
2	HLA-A*02:01 antigenIBA 05/2011 - 09/2004
2	Biomarkers (Surrogate Marker)IBA 03/2011 - 02/2010
2	AutoantibodiesIBA 03/2011 - 02/2010
2	GlycosyltransferasesIBA 10/2010 - 02/2006
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2010 - 02/2006
2	Galactose (Galactopyranose)FDA LinkGeneric 10/2010 - 09/2007
2	Membrane Proteins (Integral Membrane Proteins)IBA 10/2010 - 12/2007
2	CytokinesIBA 04/2008 - 01/2003
2	RNA (Ribonucleic Acid)IBA 02/2006 - 01/2005
2	Phenobarbital (Luminal)FDA Link 10/2004 - 04/2002
2	ChromatinIBA 12/2002 - 12/2002
2	DNA (Deoxyribonucleic Acid)IBA 12/2002 - 12/2002
1	Histones (Histone)IBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2015
1	InterferonsIBA 07/2013
1	Oncogene Proteins (Oncogene Protein)IBA 07/2013
1	Dinoprostone (PGE2)FDA Link 12/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2012
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 07/2012
1	HaptensIBA 07/2012
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 07/2012
1	Estrogen Receptor alphaIBA 12/2011
1	E-SelectinIBA 12/2011
1	Hormones (Hormone)IBA 12/2011
1	GlycosaminoglycansIBA 12/2011
1	SelectinsIBA 12/2011
1	LigandsIBA 12/2011
1	Estrogens (Estrogen)FDA Link 05/2011
1	sialosyl-Tn antigenIBA 01/2011
1	CarcinogensIBA 10/2010
1	LuciferasesIBA 04/2008
1	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2007
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2007
1	TARPIBA 02/2007
1	DisaccharidesIBA 02/2006
1	Cancer VaccinesIBA 02/2006
1	OligosaccharidesIBA 06/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2004
1	Amino Acids FDA Link 06/2003
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 04/2002
1	TransferasesIBA 04/2002
1	AutoantigensIBA 01/2002

Therapy/Procedure

9	Immunotherapy 01/2018 - 01/2002
3	Therapeutics 01/2022 - 01/2003
2	Ligation 01/2021 - 07/2012
1	Drug Therapy (Chemotherapy) 01/2015